Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNA2 | P20248 | 3/20 | 0.54 |
| ▸ | CDK2 | P24941 | 3/20 | 0.54 |
| ▸ | IGF1R | P08069 | 9/20 | 0.37 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.35 |
| ▸ | STK17B | O94768 | 1/20 | 0.35 |
| ▸ | DAPK1 | P53355 | 1/20 | 0.35 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.35 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1162153 | 0.89 | CCNA2 (0.56) | CCNA2CDK2IGF1RDAPK3STK17B | |
| SCHEMBL1162149 | 0.89 | CCNA2 (0.56) | CCNA2CDK2IGF1RDAPK3STK17B | |
| SCHEMBL1164619 | 0.86 | CCNA2 (0.72) | CCNA2CDK2IGF1RNTRK1 | |
| SCHEMBL1164620 | 0.86 | CCNA2 (0.72) | CCNA2CDK2IGF1RNTRK1 | |
| SCHEMBL1164872 | 0.80 | CCNA2 (0.49) | CCNA2CDK2IGF1R | |
| SCHEMBL1164874 | 0.80 | CCNA2 (0.49) | CCNA2CDK2IGF1R | |
| SCHEMBL12784013 | 0.80 | CCNA2 (0.74) | CCNA2CDK2IGF1RNTRK1 | |
| SCHEMBL12784975 | 0.80 | CCNA2 (0.64) | CCNA2CDK2IGF1RDAPK3STK17B | |
| SCHEMBL1164443 | 0.80 | CCNA2 (0.59) | CCNA2CDK2IGF1RDAPK3STK17B | |
| SCHEMBL1164442 | 0.80 | CCNA2 (0.59) | CCNA2CDK2IGF1RDAPK3STK17B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2464641-A1 | PYRIMIDINE COMPOUNDS AS TUBERCULOSIS INHIBITORS | Vertex Pharmaceuticals Incorporated (US) | 2012-06-20 | — | — | EP | disclosed |
| WO-2011019405-A1 | PYRIMIDINE COMPOUNDS AS TUBERCULOSIS INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-02-17 | — | — | WO | disclosed |